RSS

cell and gene therapy

Contract drug manufacturer Catalent has announced it is to acquire leading gene therapy company Paragon Bioservices for $1.2 billion. Read more

News

Digital traceability and orchestration solution for cell and gene therapies, Vineti, and specialist logistics company, World Courier, have partnered to further extend the reach of cell and gene therapies worldwide. Read more

News

Deloitte and Vineti have entered into a teaming agreement for the collaborative development of end-to-end solutions to support personalised medicine. Read more

News

Lonza Pharma & Biotech has invested in a new phase of development at its Portsmouth, New Hampshire, USA site, which will include mid-scale mammalian capacity and the addition of new cell-therapy suites. Read more

News

Gene control company, Synpromics, has been awarded a £1.9 million research and development grant from Scottish Enterprise, which will be used to expand its R&D programmes in gene regulation for cell and gene medicines. Read more

News

Integrated solutions provider, Lonza, has opened a dedicated cell-and-gene-therapy facility with the capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases. Read more

News

Integrated solutions provider, Lonza, has announced it will be establishing centres of excellence for cell and gene therapy to support and accelerate its growth in this area. Read more

News

Novartis has announced a collaboration with biotech company, Homology Medicines, to adapt and refine the technology for the treatment of a blood disorder and certain eye diseases. Read more

News

Synpromics has won the ‘best emerging UK synthetic biotech company’ at the annual OBN Awards, which celebrate innovation and achievement across the UK life sciences industry. Read more

News

Gene and cell therapy group, Oxford BioMedica (OXB), has agreed to enter into a collaboration project as lead partner that will focus on gene and cell therapy manufacturing and will be co-funded by the UK’s innovation agency, Innovate UK. Read more

News

Software developer for cell and gene therapy supply chain tracking and orchestration, TrakCel, has made a strategic appointment to further support its growth in the US. Read more

News